The activation of apoptotic cascades lead to the proteolytic cleavage of CK-18, the major intermediate filament protein in the liver and the resulting CK-18 fragments are reported to be high in liver and plasma in NAFLD and NASH patients [86,87]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.